ASP7962

DRUG3 trials

Sponsors

Astellas Pharma Europe B.V.

Conditions

Chronic Lower Back PainHealthy VolunteersOsteoarthritis of the KneePharmacokinetics of ASP7962SafetyTolerability

Phase 1

A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans

CompletedNCT01981928

Astellas Pharma Europe B.V.Pharmacokinetics of ASP7962, Safety, Tolerability

Start: 2013-11-30End: 2014-05-31Updated: 2014-07-11

A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy Subjects

CompletedNCT02136316

Astellas Pharma Europe B.V.Healthy Volunteers, Pharmacokinetics of ASP7962

Start: 2014-05-31End: 2015-11-30Updated: 2015-12-15

Phase 2

A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee

CompletedNCT02611466

Astellas Pharma Europe B.V.Chronic Lower Back Pain, Osteoarthritis of the Knee

Start: 2016-02-16End: 2017-09-29Updated: 2024-10-31

Related Papers

Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial.

2019-07-2625 citations